
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRCK34 | B3 | BRL | Delayed | |
MRK | NYSE | USD | Real-time | |
0QAH | London | USD | Real-time | |
MRK | Mexico | MXN | Delayed | |
1MRKX | Milan | EUR | Real-time | |
MRK | Frankfurt | EUR | Delayed | |
MRK | TradeGate | EUR | Delayed | |
MRK | Xetra | EUR | Delayed | |
MRKm | Buenos Aires | ARS | Delayed | |
MRK | Vienna | EUR | Real-time | |
MRK | Ukraine | UAH | Delayed | |
MRK | Lima | USD | Delayed |
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Patricia F. Russo | 70 | 1995 | Independent Director |
Thomas Henry Glocer | 63 | 2007 | Independent Lead Director |
Pamela J. Craig | 65 | 2015 | Independent Director |
Robert M. Davis | 55 | 2014 | CEO & Chairman |
Paul B. Rothman | 66 | 2015 | Independent Director |
Inge G. Thulin | 70 | 2018 | Independent Director |
Mary Ellen Coe | 57 | 2019 | Independent Director |
Kathy J. Warden | 52 | 2020 | Independent Director |
Risa J. Lavizzo-Mourey | 69 | 2020 | Independent Director |
Douglas M. Baker | 65 | 2022 | Independent Director |
Christine E. Seidman | 71 | 2020 | Independent Director |
Stephen L. Mayo | 62 | 2021 | Independent Director |
Surendralal Lanca Karsanbhai | 55 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review